botox
The lineup of Allergan products reads like a Hollywood starlet's wish list: Botox, breast implants, Latisse. Last week, the company reported 14% higher quarterly sales, aided by a 16% surge in Botox sales. The company also boosted its full-year sales forecast despite the market's reacting violently to a possible recession and sovereign debt issues. Is Botox really recession-resistant? Can the company manage yet another possible recession?
Cosmetic Surgery: Are the Payoffs Worth the Price?
8:00AM 8/09/2011
Despite the recession, the cosmetic procedure industry has continued to grow across the board, with injectables creating a whole new business line in the industry of youthful appearance. But what do patients really get out of these procedures -- and are they worth the money?
More people are getting everything from facelifts to liposuction these days. And it's the so-called less vain sex who is helping to drive those plastic surgery numbers up.
New statistics from the American Society of Plastic Surgeons revealed that cosmetic plastic surgery procedures among men rose...
Despite high unemployment and a dismal economy, there is one splurge Americans can't seem to give up: plastic surgery.
According to the American Society of Plastic Surgeons (ASPS), cosmetic procedures climbed 5% in 2010, totaling 13.1 million procedures. More than 5.3 million reconstructive...
Judge Approves $600 Million Botox Settlement
3:15AM 10/06/2010
A judge has finalized Allergan's $600 million settlement over the misleading marketing of its wrinkle-smoothing Botox medication. The pharmaceutical firm plead guilty to misbranding the product.
Legal Briefing: Allergan Pays $600 Million to Settle Botox Charges
11:34AM 9/03/2010
Pharmaceutical firm Allergan has settled criminal and civil charges that it promoted Botox for uses the FDA hadn't approved, agreeing to pay $600 million and enter into a "corporate integrity agreement." Allergan also dropped its related First Amendment lawsuit against the FDA.
Botox may ease wrinkles, but a $600 million government fine today of its manufacturer Allergan is making clear it's not a legal remedy for headaches, pains and juvenile cerebral palsy.
The Justice Department today came down hard on Allergan for making such claims, announcing a settlement that has...
Cosmetic perjury: Botox bandits on the rise, hurting industry
3:30PM 8/06/2010
You've heard of dine and dash. But Botox and bail? That's what some people are doing in this tough economy -- going in for popular cosmetic procedures like Botox and then failing to pay the bill. Surgeons from California to Conneticut told WalletPop that they've noticed an uptick in these types of...
A North Texas woman who unlawfully sold Botox-like injections and other prescription drugs online has agreed to stop as part of a lawsuit settlement with the state.
Last November, the Texas Attorney General sued Laurie D'Alleva and her Mansfield-based business, Discount Medspa and Ontario Medspa,...
The pharmaceutical company known for beauty products such as Botox and Natrelle breast implants now faces unwelcome attention prompted by the way its new drug created for people who want longer, lusher eyelashes is being sold, and the side effects it causes.
A number of consumers say they weren't...
More Stories
Next Page →Market Movers
| Symbol | Last | Change / % | Volume |
|---|
Most Actives
| 8.07 | -0.11 -1.34% | 254.23M | |
| 2.19 | +0.25 +12.89% | 122.18M | |
| 18.88 | -0.26 -1.33% | 109.55M | |
| 12.44 | -0.25 -1.97% | 52.49M |
% Gainers
| 31.68 | +7.78 +32.55% | 18.42M | |
| 89.96 | +13.57 +17.76% | 13.27M | |
| 2.19 | +0.25 +12.89% | 122.18M | |
| 10.50 | +1.10 +11.70% | 3.07M |
% Losers
DailyFinance Wire
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
- Why Used Car Bargains Are Getting Harder to Find
- 5 Reasons Facebook Stock May Be a Better Buy Than You Think
Newswire
- Staff at The Sun tabloid arrested in bribe...
- Greece's grim choice: deep budget cuts or...
- Greek premier defends bailout deal, painful...
- Faces beyond the numbers of long-term...
- Obama budget: New spending with recycled tax...
- Obama budget seeks to boost trade enforcement
- As Facebook IPO nears, the case for dull stocks
- Turbo-traders take Bank of America for a ride
- Getting paid $35,000 to short sell
- What the $26B settlement means for you
- Investing your emergency cash: Return vs. risk
- First Premier's $400-a-year credit card
- Big banks' bloated mortgage tab
- Fewer young adults hold jobs than ever before
- Government assistance expands
- Bob Rodriguez: The best advice I ever got
- 24/7 Wall St. Top Analyst Calls of the Week (AONE, ALU, AMSC, NLY, AAPL, CSCO, COH, CSTR, COP, DLR, IBM, LF, MMM, M, OPEN, POST, SIRI, SOHU, TRLG, ZOLT)
- The Force: Star Wars Franchise Worth Over $30 Billion and Growing
- 24/7 Wall St. Closing Bell (COP, GILD, AMSC, MA, COH, LNKD, ATVI, CPST, GPRE, KONA, TRLG, LGF, MOVE, NBL, PCYC, ALU, FLIR, RUTH, FSLR, CIE, TBAC, RPXC, AMRS)
- Mid-day Movers (CIE, AMRS, IPSU, MOVE, LNKD)
- Petrobras Shares Volatile on $225 Billion Development Plan (PBR)
- Morning Movers (CIE, ALU, LNKD, AMRS, XIDE)
- AEP Dividend Growth Still Looks Safe Ahead (AEP)
- Arch Coal Tumbles on Earnings, Forecast (ACI, ANR, PCX, BTU, CNX)
Follow Us
